Literature DB >> 17194668

Intractable myoclonus associated with anti-GluR3 antibodies after allogeneic bone marrow transplantation.

Claudio Solaro1, Renato Mantegazza, Andrea Bacigalupo, Antonio Uccelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17194668

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  4 in total

Review 1.  Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-08-01       Impact factor: 3.575

2.  Antibodies Against the NH2-Terminus of the GluA Subunits Affect the AMPA-Evoked Releasing Activity: The Role of Complement.

Authors:  Francesca Cisani; Guendalina Olivero; Cesare Usai; Gilles Van Camp; Stefania Maccari; Sara Morley-Fletcher; Anna Maria Pittaluga
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 3.  Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights.

Authors:  Mia Levite; Hadassa Goldberg
Journal:  Front Immunol       Date:  2022-01-12       Impact factor: 7.561

4.  Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment.

Authors:  Maria Chiara Buscarinu; Arianna Fornasiero; Giulia Pellicciari; Roberta Reniè; Anna Chiara Landi; Alessandro Bozzao; Cristina Cappelletti; Pia Bernasconi; Giovanni Ristori; Marco Salvetti
Journal:  Brain Sci       Date:  2019-10-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.